of 61 windows beat the index

Hem Securities - Dynamic Research and Emerging Asset
What this strategy is
DREAM is a multi-cap strategy consisting of 25 high conviction stocks across various sectors, with maximum allocation to a single sector being not more than 25%. Companies with strong fundamentals which appear attractive for a long term horizon are shortlisted for further analysis before it becomes a part of our portfolio.
- This strategy₹3.15 Cr
- S&P BSE 500 Total Return Index₹2.35 Cr
Illustrative monthly path, net of fees, modelled to the strategy's since-inception CAGR versus the S&P BSE 500 Total Return Index. Not the actual NAV series; past performance is not indicative of future returns.
Trailing returns vs benchmark
Absolute for windows under a year, annualised (CAGR) beyond. Alpha is the strategy minus its benchmark.
This strategyHow often it has beaten the index
Across every rolling holding period in the modelled history — the longer you hold, the more the odds have favoured the strategy.
of 37 windows beat the index
of 13 windows beat the index
Computed on an illustrative monthly path modelled to the since-inception CAGR — not the actual NAV series.
The quality of those returns
Returns mean little without the ride that earned them.
A Sharpe of 0.70 means it earned a modest return for each unit of risk taken. Size the position so a drawdown of that order is one you can sit through.
Under the hood — where the money sits
Spread across the market-cap curve.
- Cash / Debt100%
Top holdings and the sector book stream from the live feed — ask Nyra for the current portfolio.
Who runs the money
A strategy is only as good as the hand on the wheel.
Hem Securities's Multi Cap approach blends valuation discipline with growth conviction, tilting toward whichever side the cycle is paying for. It is benchmarked to the S&P BSE 500 Total Return Index but invests with conviction rather than hugging the index.
A focused book of roughly 30–40 holdings means the highest-conviction ideas actually move the portfolio.
A 6-year track record across rallies and drawdowns — positioning shifts with the cycle rather than chasing the last quarter.
Drawdowns are managed deliberately; the worst peak-to-trough on record is kept in check.
A high-conviction multi cap strategy with a strong scorecard.
Nyra scores Hem Securities - Dynamic Research and Emerging Asset 8.5/10, on a since-inception CAGR near 21.1% and a 3-year CAGR of 20.1%. Drawdowns have stayed contained — size the position so that ride is one you can hold.
Investors with a 5-year-plus horizon who want active Multi Cap exposure and can sit through equity drawdowns.
A double-digit drawdown would test your nerve, or you need ₹50 L+ to commit at the SEBI minimum.
A steadier core (large-cap or hybrid) so this can play the higher-conviction satellite in your overall allocation.
The fine print, in plain sight
- Inception
- Mar 2020
- Track record
- 6 years
- Category
- Equity: Multi Cap
- Style
- Blend
- Benchmark
- S&P BSE 500 Total Return Index
- Holdings
- —
- Fixed fee
- 2.50% fixed
- Performance fee
- 20% over 10.00% hurdle
- Minimum investment
- ₹50 L
- Lock-in / exit
- Exit Load: 1 Year: 1.00%, 2 Year: 0.00%, 3 Year: 0.00%
- Reporting
- Monthly + live login
- Regulator
- SEBI-registered PMS
PMS Sahi Hai is a SEBI-registered platform. Figures are sourced from the strategy's disclosures and the live feed; the growth chart, rolling-window and risk figures are modelled to the disclosed since-inception CAGR (illustrative, not the actual NAV series). Returns are net of fees where stated. Investments in PMS, AIF and GIFT City strategies are subject to market risk — past performance is not indicative of future results. This page is information, not investment advice.
“I held two PMS for four years and couldn't tell you why. One 15-minute review showed me the overlap, the real post-tax number, and one fund worth replacing. Nobody had ever shown me that math.”
Composite client stories — names changed, numbers preserved.
Hem Securities - Dynamic Research and Emerging Asset — common questions
What is Hem Securities - Dynamic Research and Emerging Asset?
Hem Securities - Dynamic Research and Emerging Asset is a Multi Cap PMS strategy from Hem Securities. It follows a Blend style, is benchmarked to the S&P BSE 500 Total Return Index, and carries a Nyra score of 8.5/10.
Who should consider Hem Securities - Dynamic Research and Emerging Asset?
It suits investors with a five-year-plus horizon who want active Multi Cap exposure and can stay invested through market drawdowns. The SEBI minimum is ₹50 L.
What returns has it delivered?
Since inception (Mar 2020) it has compounded at roughly 21.1% a year, with a 3-year CAGR of 20.1% against 13.6% for the S&P BSE 500 Total Return Index. Returns are net of fees; past performance is not a guarantee of future results.
What are the fees and lock-in?
2.50% fixed, with a performance fee of 20% over 10.00% hurdle. Exit / lock-in terms: Exit Load: 1 Year: 1.00%, 2 Year: 0.00%, 3 Year: 0.00%.
How risky is it?
Like all market-linked products it can fall in value; the worst drawdown on record is disclosed in the factsheet. Hem Securities is SEBI-registered and reports monthly. This page is information, not investment advice.
